
Mishukan 2.5mg/1mg Tablet
Marketer
Assure Pharma
Salt Composition
Trifluoperazine (2.5mg) + Trihexyphenidyl (1mg)
Overview Mishukan 2.5mg/1mg Tablet
Combiflex 2.5mg/1mg tablets are a dual-action medication prescribed for schizophrenia, a condition characterized by distorted perceptions and behaviors. This formulation modifies thought patterns, elevates mood, and improves cognitive function, emotional regulation, and conduct. Combiflex 2.5mg/1mg also enhances motor control and alleviates muscle rigidity. It can be administered with or without food, ideally at the same time daily for consistent blood levels. Follow your physician's dosage and treatment duration instructions; if a dose is missed, take it upon recollection. Complete the prescribed course, even with symptom improvement. Abrupt cessation should be avoided; consult your doctor before discontinuing. Potential side effects include nausea, constipation, dry mouth, drowsiness, irregular heartbeat, urinary retention, blurred vision, and anxiety. Initial postural hypotension may occur; rise slowly from sitting or lying positions. Dizziness and somnolence are possible; avoid driving or activities requiring alertness until effects are known. Prior to treatment, disclose any thyroid, kidney, epilepsy, Parkinson's disease, glaucoma, or heart conditions. Concurrent use with alcohol or sedatives, cough, or allergy medications is contraindicated. Weight gain is a potential consequence; maintain a nutritious diet, limit high-calorie snacks, and engage in regular physical activity.
Uses of Mishukan 2.5mg/1mg Tablet
Split personality disorder
Major Benefits of Mishukan 2.5mg/1mg Tablet:
Administer this medication precisely as your physician directs, adhering to both the prescribed dosage and treatment length. Ingest the 2.5mg/1mg Mishukan tablet whole; avoid chewing, crushing, or fracturing it. Consumption may coincide with meals or be taken independently, though consistent timing is recommended.
Common Side effects of Mishukan 2.5mg/1mg Tablet:
- Nausea
- Constipation
- Dryness in mouth
- Sedation
- Weight gain
- Orthostatic hypotension (sudden lowering of blood pressure on standing)
- Urinary retention
- Increased prolactin level in blood
- Dizziness
- Blurred vision
- Nervousness
How to use Mishukan 2.5mg/1mg Tablet:
Administer this medication precisely as your physician directs, adhering to both the prescribed dosage and treatment duration. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Mishukan 2.5mg/1mg Tablets can be consumed with or without food, although consistent timing is recommended.
How Mishukan 2.5mg/1mg Tablet works:
Mishukan 2.5mg/1mg tablets contain trifluoperazine and trihexyphenidyl, two medications working synergistically. Trifluoperazine, a conventional antipsychotic, modulates brain chemistry by antagonizing dopamine, a neurotransmitter influencing mood and cognition. This action, while beneficial, can sometimes lead to extrapyramidal symptoms like tremors or muscle stiffness. Trihexyphenidyl is included to mitigate these potential adverse effects.
SAFETY ADVICE
AlcoholUNSAFE
Concomitant use of Mishukan 2.5mg/1mg tablets and alcohol may result in pronounced somnolence.
PregnancyCONSULT YOUR DOCTOR
The use of Mishukan 2.5mg/1mg Tablet during pregnancy may pose risks. While human data is scarce, animal studies indicate potential harm to the fetus. A physician will assess the advantages against potential hazards prior to prescribing. Physician consultation is advised.
Breast feedingCONSULT YOUR DOCTOR
Lactation and the use of Mishukan 2.5mg/1mg tablets are likely incompatible. Available human data indicates potential transfer of the drug to breast milk, posing a possible risk to the infant.
DrivingUNSAFE
Driving ability may be impaired by side effects of Mishukan 2.5mg/1mg Tablet. These side effects can include blurred vision, dizziness, mild nausea, and, in some instances, cognitive impairment.
KidneyCONSULT YOUR DOCTOR
Insufficient data exists regarding Mishukan 2.5mg/1mg Tablet use in individuals with renal impairment. Medical supervision is advised. Close physician monitoring is necessary for patients with kidney disease receiving this medication.
LiverCONSULT YOUR DOCTOR
Insufficient data exists regarding the use of Mishukan 2.5mg/1mg tablets in individuals with hepatic impairment. Physician consultation is advised.
What if you forget to take Mishukan 2.5mg/1mg Tablet :
Should you forget a dose of Mishukan 2.5mg/1mg Tablet, administer it at your earliest convenience. If, however, your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About Mishukan 2.5mg/1mg Tablet
| Label | Value |
|---|---|
| Potential for Dependence | None. |
| Type of Medication | Central and peripheral nervous system |
